These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28842631)

  • 21. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
    Ashraf GM; DasGupta D; Alam MZ; Baeesa SS; Alghamdi BS; Anwar F; Alqurashi TMA; Sharaf SE; Al Abdulmonem W; Alyousef MA; Alhumaydhi FA; Shamsi A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
    Aneja B; Khan NS; Khan P; Queen A; Hussain A; Rehman MT; Alajmi MF; El-Seedi HR; Ali S; Hassan MI; Abid M
    Eur J Med Chem; 2019 Feb; 163():840-852. PubMed ID: 30579124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
    Anwar S; Shahwan M; Hasan GM; Islam A; Hassan MI
    Cell Signal; 2022 Nov; 99():110434. PubMed ID: 35961526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4.
    Anwar S; Khan S; Anjum F; Shamsi A; Khan P; Fatima H; Shafie A; Islam A; Hassan MI
    J Cell Biochem; 2022 Feb; 123(2):359-374. PubMed ID: 34751461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.
    Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C
    Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ubiquitin-associated domain of MARK4 provides stability at physiological pH.
    Naz F; Sami N; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2016 Dec; 93(Pt A):1147-1154. PubMed ID: 27677563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro.
    Naz F; Islam A; Ahmad F; Hassan MI
    Mol Cell Biochem; 2015 Dec; 410(1-2):223-8. PubMed ID: 26346160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microtubule affinity-regulating kinase 4: structure, function, and regulation.
    Naz F; Anjum F; Islam A; Ahmad F; Hassan MI
    Cell Biochem Biophys; 2013 Nov; 67(2):485-99. PubMed ID: 23471664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MARK4 protein can explore the active-like conformations in its non-phosphorylated state.
    Ahrari S; Khosravi F; Osouli A; Sakhteman A; Nematollahi A; Ghasemi Y; Savardashtaki A
    Sci Rep; 2019 Sep; 9(1):12967. PubMed ID: 31506531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thienopyrimidine-Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells.
    Khan NS; Khan P; Ansari MF; Srivastava S; Hasan GM; Husain M; Hassan MI
    Mol Pharm; 2018 Sep; 15(9):4173-4189. PubMed ID: 30040903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes.
    Liu Z; Gan L; Chen Y; Luo D; Zhang Z; Cao W; Zhou Z; Lin X; Sun C
    Sci Rep; 2016 Feb; 6():21382. PubMed ID: 26888669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
    Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
    Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel molecular probes of the Rio1 atypical protein kinase.
    Mielecki M; Krawiec K; Kiburu I; Grzelak K; Zagórski W; Kierdaszuk B; Kowa K; Fokt I; Szymanski S; Swierk P; Szeja W; Priebe W; Lesyng B; LaRonde-LeBlanc N
    Biochim Biophys Acta; 2013 Jul; 1834(7):1292-301. PubMed ID: 23523885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of Phosphodiesterase-1 Inhibitory Effect of Some Selected Natural Polyphenolics Using In Vitro and In Silico Methods.
    Rauf A; Orhan IE; Ertas A; Temel H; Hadda TB; Saleem M; Raza M; Khan H
    Curr Top Med Chem; 2017; 17(4):412-417. PubMed ID: 27558680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a high affinity selective inhibitor of Polo-like kinase 1 for cancer chemotherapy by computational approach.
    Kumar M; Pydi SP; Sharma S; Singh TP; Kaur P
    J Mol Graph Model; 2014 Jun; 51():104-12. PubMed ID: 24879322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphenolics from mango (Mangifera indica L.) suppress breast cancer ductal carcinoma in situ proliferation through activation of AMPK pathway and suppression of mTOR in athymic nude mice.
    Nemec MJ; Kim H; Marciante AB; Barnes RC; Hendrick ED; Bisson WH; Talcott ST; Mertens-Talcott SU
    J Nutr Biochem; 2017 Mar; 41():12-19. PubMed ID: 27951515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.
    Atiya A; Das Gupta D; Alsayari A; Alrouji M; Alotaibi A; Sharaf SE; Abdulmonem WA; Alorfi NM; Abdullah KM; Shamsi A
    ACS Omega; 2023 Feb; 8(7):6423-6430. PubMed ID: 36844587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold.
    Naz H; Jameel E; Hoda N; Shandilya A; Khan P; Islam A; Ahmad F; Jayaram B; Hassan MI
    Bioorg Med Chem Lett; 2016 Feb; 26(3):782-788. PubMed ID: 26783179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
    Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
    Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases.
    Baby B; Antony P; Al Halabi W; Al Homedi Z; Vijayan R
    Drug Des Devel Ther; 2016; 10():3109-3123. PubMed ID: 27729770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.